Regenxbio Inc(RGNX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

RGNX Regenxbio Inc

盘后交易 11-15 18:24:10 EST

9.63

-1.51

-13.55%

盘后9.95

+0.32+3.32%

17:54 EST

最高11.63	最低9.58	成交量128.47万
今开11.56	昨收11.14	日振幅18.40%
总市值4.77亿	流通市值3.94亿	总股本4,955万
成交额1,289万	换手率3.14%	流通股本4,092万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"RGNX","market":"US","secType":"STK","nameCN":"Regenxbio Inc","latestPrice":9.63,"timestamp":1731704400000,"preClose":11.14,"halted":0,"volume":1284733,"hourTrading":{"tag":"盘后","latestPrice":9.95,"preClose":9.63,"latestTime":"17:54 EST","volume":11001,"amount":106462.6890465,"timestamp":1731711269685},"delay":0,"floatShares":40923886,"shares":49545071,"eps":-4.997044,"marketStatus":"盘后交易","marketStatusCode":4,"change":-1.51,"latestTime":"11-15 18:24:10 EST","open":11.56,"high":11.63,"low":9.58,"amount":12890058.934847,"amplitude":0.184022,"askPrice":10.1,"askSize":28,"bidPrice":9.57,"bidSize":500,"shortable":0,"etf":0,"ttmEps":-4.997044,"exchange":"NASDAQ","tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1731718800000},"adr":0,"listingDate":1442462400000,"adjPreClose":11.14,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":11.5497,"preClose":11.14,"latestTime":"08:08 EST","volume":201,"amount":2271.549843,"timestamp":1731676080552},"postHourTrading":{"tag":"盘后","latestPrice":9.95,"preClose":9.63,"latestTime":"17:54 EST","volume":11001,"amount":106462.6890465,"timestamp":1731711269685},"volumeRatio":1.491954,"impliedVol":1.9339,"impliedVolPercentile":0.9921},"requestUrl":"/m/hq/s/RGNX/tweets","defaultTab":"tweets","newsList":[{"id":"2483306018","title":"Regenxbio Inc.2024财年第三财季实现净利润-59.60百万美元，同比增加3.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483306018","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483306018?lang=zh_cn&edition=full","pubTime":"2024-11-16 00:00","pubTimestamp":1731686429,"startTime":"0","endTime":"0","summary":"11月16日，Regenxbio Inc.公布财报，公告显示公司2024财年第三财季净利润为-59.60百万美元，同比增加3.67%；其中营业收入为24.20百万美元，同比减少16.29%，每股基本收益为-1.17美元。从资产负债表来看，Regenxbio Inc.总负债2.18亿美元，其中短期债务34.42百万美元，资产负债比为2.39，流动比率为3.04。机构评级：截至2024年11月16日，当前有11家机构对Regenxbio Inc.目标价做出预测，其中目标均价为35.73美元，其中最低目标价为18.00美元，最高目标价为52.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116000212abc514b4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116000212abc514b4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RGNX"],"gpt_icon":0},{"id":"2483809769","title":"Regenxbio Inc.盘中异动 股价大涨5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483809769","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483809769?lang=zh_cn&edition=full","pubTime":"2024-11-14 22:31","pubTimestamp":1731594665,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日22时31分，Regenxbio Inc.股票出现异动，股价急速上涨5.06%。截至发稿，该股报11.21美元/股，成交量2.7996万股，换手率0.06%，振幅4.50%。Regenxbio Inc.股票所在的生物技术行业中，整体跌幅为0.42%。Regenxbio Inc.公司简介：Regenxbio Inc是一家生物技术公司。Regenxbio平台针对的疾病是代谢性疾病、神经退行性疾病和视网膜疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114223105971a68b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114223105971a68b5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4563","RGNX","BK4505"],"gpt_icon":0},{"id":"2481854189","title":"Regenxbio Inc.盘中异动 早盘急速拉升5.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481854189","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481854189?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:31","pubTimestamp":1730903517,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日22时31分，Regenxbio Inc.股票出现波动，股价快速拉升5.72%。截至发稿，该股报9.43美元/股，成交量1.0545万股，换手率0.02%，振幅104.76%。Regenxbio Inc.股票所在的生物技术行业中，整体涨幅为0.91%。Regenxbio Inc.公司简介：Regenxbio Inc是一家生物技术公司。Regenxbio平台针对的疾病是代谢性疾病、神经退行性疾病和视网膜疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106223157a21d2a51&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106223157a21d2a51&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4563","BK4139","BK4505","RGNX"],"gpt_icon":0},{"id":"2479325547","title":"Regenxbio Inc.盘中异动 快速下跌5.05%报8.91美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479325547","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479325547?lang=zh_cn&edition=full","pubTime":"2024-10-30 03:14","pubTimestamp":1730229267,"startTime":"0","endTime":"0","summary":"北京时间2024年10月30日03时14分，Regenxbio Inc.股票出现异动，股价大幅下跌5.05%。截至发稿，该股报8.91美元/股，成交量27.4857万股，换手率0.56%，振幅5.70%。Regenxbio Inc.股票所在的生物技术行业中，整体跌幅为0.27%。其相关个股中，Glycomimetics, Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Lixte Biotechnology Holdings, Inc.涨幅较大，Glycomimetics, Inc.、Lixte Biotechnology Holdings, Inc.、Novabay Pharmaceuticals, Inc.较为活跃，换手率分别为1626.50%、1420.23%、355.86%，振幅较大的相关个股有Glycomimetics, Inc.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Dermata Therapeutics Inc C/Wts ，振幅分别为183.65%、88.24%、78.31%。Regenxbio Inc.公司简介：Regenxbio Inc是一家生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030031427971a2ffa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030031427971a2ffa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4563","RGNX","BK4505"],"gpt_icon":0},{"id":"2477898281","title":"Regenxbio Inc.盘中异动 股价大跌5.23%报10.52美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477898281","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477898281?lang=zh_cn&edition=full","pubTime":"2024-10-22 00:04","pubTimestamp":1729526655,"startTime":"0","endTime":"0","summary":"北京时间2024年10月22日00时04分，Regenxbio Inc.股票出现异动，股价急速下挫5.23%。截至发稿，该股报10.52美元/股，成交量25.444万股，换手率0.51%，振幅6.40%。Regenxbio Inc.股票所在的生物技术行业中，整体跌幅为0.62%。其相关个股中，Genprex, Inc.、Biovie Inc.、Gri Bio, Inc.涨幅较大，Genprex, Inc.、Gri Bio, Inc.、Biovie Inc.较为活跃，换手率分别为6878.47%、3235.29%、1399.63%，振幅较大的相关个股有Genprex, Inc.、Biovie Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为369.73%、157.02%、148.15%。Regenxbio Inc.公司简介：Regenxbio Inc是一家生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102200041598e3d946&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102200041598e3d946&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4563","BK4139","BK4505","RGNX"],"gpt_icon":0},{"id":"2476299404","title":"Regenxbio Inc.盘中异动 下午盘急速拉升5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2476299404","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476299404?lang=zh_cn&edition=full","pubTime":"2024-10-19 02:05","pubTimestamp":1729274712,"startTime":"0","endTime":"0","summary":"北京时间2024年10月19日02时05分，Regenxbio Inc.股票出现波动，股价快速上涨5.00%。截至发稿，该股报11.13美元/股，成交量21.8483万股，换手率0.44%，振幅4.15%。机构评级方面，在所有10家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Regenxbio Inc.股票所在的生物技术行业中，整体涨幅为0.26%。Regenxbio Inc.公司简介：Regenxbio Inc是一家生物技术公司。Regenxbio平台针对的疾病是代谢性疾病、神经退行性疾病和视网膜疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241019020512a1e1c6b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241019020512a1e1c6b5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RGNX","BK4563","BK4505","BK4139"],"gpt_icon":0},{"id":"2475911617","title":"Regenxbio Inc.盘中异动 早盘快速上涨5.05%报10.82美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2475911617","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475911617?lang=zh_cn&edition=full","pubTime":"2024-10-16 22:55","pubTimestamp":1729090509,"startTime":"0","endTime":"0","summary":"北京时间2024年10月16日22时55分，Regenxbio Inc.股票出现波动，股价急速上涨5.05%。截至发稿，该股报10.82美元/股，成交量6.6151万股，换手率0.13%，振幅4.85%。Regenxbio Inc.股票所在的生物技术行业中，整体跌幅为0.34%。其相关个股中，180 Life Sciences Corp.、180 Life Sciences Corp C/Wts 07/11/2025、Korro Bio, Inc.涨幅较大，180 Life Sciences Corp.、Biodexa Pharmaceuticals Plc、Quoin Pharmaceuticals Ltd较为活跃，换手率分别为5695.94%、1041.50%、395.32%，振幅较大的相关个股有180 Life Sciences Corp.、180 Life Sciences Corp C/Wts 07/11/2025、Klotho Neurosciences Inc C/Wts 21/06/2029 ，振幅分别为623.68%、279.52%、121.40%。Regenxbio Inc.公司简介：Regenxbio Inc是一家生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241016225509971a0a7d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241016225509971a0a7d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","RGNX","BK4563"],"gpt_icon":0},{"id":"2474501165","title":"Regenxbio Inc.盘中异动 临近午盘股价大涨5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474501165","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474501165?lang=zh_cn&edition=full","pubTime":"2024-10-11 23:51","pubTimestamp":1728661871,"startTime":"0","endTime":"0","summary":"北京时间2024年10月11日23时51分，Regenxbio Inc.股票出现异动，股价快速上涨5.06%。截至发稿，该股报9.76美元/股，成交量11.3674万股，换手率0.23%，振幅5.64%。Regenxbio Inc.股票所在的生物技术行业中，整体涨幅为0.89%。Regenxbio Inc.公司简介：Regenxbio Inc是一家生物技术公司。Regenxbio平台针对的疾病是代谢性疾病、神经退行性疾病和视网膜疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241011235111a1e006b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241011235111a1e006b9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","RGNX","BK4563"],"gpt_icon":0},{"id":"2472142856","title":"Regenxbio Inc.盘中异动 早盘快速下挫5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2472142856","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472142856?lang=zh_cn&edition=full","pubTime":"2024-10-03 22:30","pubTimestamp":1727965809,"startTime":"0","endTime":"0","summary":"北京时间2024年10月03日22时30分，Regenxbio Inc.股票出现波动，股价快速下跌5.04%。截至发稿，该股报9.42美元/股，成交量11.824万股，换手率0.24%，振幅3.33%。Regenxbio Inc.股票所在的生物技术行业中，整体跌幅为0.77%。Regenxbio Inc.公司简介：Regenxbio Inc是一家生物技术公司。Regenxbio平台针对的疾病是代谢性疾病、神经退行性疾病和视网膜疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410032230109719e346&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410032230109719e346&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4563","RGNX","BK4505"],"gpt_icon":0},{"id":"2470330400","title":"Regenxbio Inc.盘中异动 大幅上涨5.15%报11.23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2470330400","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470330400?lang=zh_cn&edition=full","pubTime":"2024-09-27 23:21","pubTimestamp":1727450493,"startTime":"0","endTime":"0","summary":"北京时间2024年09月27日23时21分，Regenxbio Inc.股票出现波动，股价大幅拉升5.15%。截至发稿，该股报11.23美元/股，成交量9.9306万股，换手率0.20%，振幅3.65%。Regenxbio Inc.股票所在的生物技术行业中，整体跌幅为0.30%。Regenxbio Inc.公司简介：Regenxbio Inc是一家生物技术公司。Regenxbio平台针对的疾病是代谢性疾病、神经退行性疾病和视网膜疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092723213398e39706&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092723213398e39706&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RGNX","BK4563","BK4505","BK4139"],"gpt_icon":0},{"id":"2468072620","title":"Regenxbio Inc.盘中异动 早盘大幅下挫5.04%报11.87美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2468072620","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468072620?lang=zh_cn&edition=full","pubTime":"2024-09-20 23:13","pubTimestamp":1726845195,"startTime":"0","endTime":"0","summary":"北京时间2024年09月20日23时13分，Regenxbio Inc.股票出现异动，股价大幅下跌5.04%。截至发稿，该股报11.87美元/股，成交量18.5774万股，换手率0.38%，振幅4.48%。Regenxbio Inc.股票所在的生物技术行业中，整体跌幅为1.59%。Regenxbio Inc.公司简介：Regenxbio Inc是一家生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240920231315ab64e79e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240920231315ab64e79e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4563","BK4505","RGNX"],"gpt_icon":0},{"id":"2461884489","title":"Regenxbio Inc.盘中异动 股价大跌5.05%报11.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2461884489","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461884489?lang=zh_cn&edition=full","pubTime":"2024-08-21 00:55","pubTimestamp":1724172924,"startTime":"0","endTime":"0","summary":"北京时间2024年08月21日00时55分，Regenxbio Inc.股票出现波动，股价快速下跌5.05%。截至发稿，该股报11.85美元/股，成交量8.0061万股，换手率0.16%，振幅5.29%。Regenxbio Inc.股票所在的生物技术行业中，整体涨幅为0.06%。Regenxbio Inc.公司简介：Regenxbio Inc是一家生物技术公司。Regenxbio平台针对的疾病是代谢性疾病、神经退行性疾病和视网膜疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240821005525a1d53f67&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240821005525a1d53f67&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","RGNX","BK4563","BK4139"],"gpt_icon":0},{"id":"2459471468","title":"Regenxbio Inc.盘中异动 早盘股价大涨5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459471468","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459471468?lang=zh_cn&edition=full","pubTime":"2024-08-15 23:10","pubTimestamp":1723734615,"startTime":"0","endTime":"0","summary":"北京时间2024年08月15日23时10分，Regenxbio Inc.股票出现波动，股价大幅拉升5.20%。截至发稿，该股报12.55美元/股，成交量6.0785万股，换手率0.12%，振幅3.56%。Regenxbio Inc.股票所在的生物技术行业中，整体涨幅为0.94%。Regenxbio Inc.公司简介：Regenxbio Inc是一家生物技术公司。Regenxbio平台针对的疾病是代谢性疾病、神经退行性疾病和视网膜疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815231015ab5ddbe9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815231015ab5ddbe9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4563","RGNX","BK4505"],"gpt_icon":0},{"id":"2458515207","title":"Regenxbio Inc.2024财年第二财季实现净利润-52.99百万美元，同比增加26.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2458515207","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458515207?lang=zh_cn&edition=full","pubTime":"2024-08-10 00:22","pubTimestamp":1723220530,"startTime":"0","endTime":"0","summary":"8月10日，Regenxbio Inc.公布财报，公告显示公司2024财年第二财季净利润为-52.99百万美元，同比增加26.46%；其中营业收入为22.30百万美元，同比增加11.61%，每股基本收益为-1.05美元。从资产负债表来看，Regenxbio Inc.总负债2.21亿美元，其中短期债务39.40百万美元，资产负债比为2.58，流动比率为0.04。机构评级：截至2024年8月10日，当前有10家机构对Regenxbio Inc.目标价做出预测，其中目标均价为39.40美元，其中最低目标价为28.00美元，最高目标价为52.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408100022179f1e13d9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408100022179f1e13d9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RGNX"],"gpt_icon":0},{"id":"2457287160","title":"Regenxbio Inc.盘中异动 临近收盘股价大跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457287160","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457287160?lang=zh_cn&edition=full","pubTime":"2024-08-08 03:54","pubTimestamp":1723060481,"startTime":"0","endTime":"0","summary":"北京时间2024年08月08日03时54分，Regenxbio Inc.股票出现波动，股价急速下跌5.04%。截至发稿，该股报12.05美元/股，成交量37.0276万股，换手率0.75%，振幅7.88%。Regenxbio Inc.股票所在的生物技术行业中，整体跌幅为2.33%。Regenxbio Inc.公司简介：Regenxbio Inc是一家生物技术公司。Regenxbio平台针对的疾病是代谢性疾病、神经退行性疾病和视网膜疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808035442af966dc4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808035442af966dc4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","BK4563","RGNX"],"gpt_icon":0},{"id":"1162437426","title":"异动解读 | Regenxbio Inc.盘中大涨5%,机构看好公司前景","url":"https://stock-news.laohu8.com/highlight/detail?id=1162437426","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1162437426?lang=zh_cn&edition=full","pubTime":"2024-08-07 02:22","pubTimestamp":1722968547,"startTime":"0","endTime":"0","summary":"北京时间2024年8月7日,生物技术公司Regenxbio Inc.(RGNX)股价在盘中出现大涨,最高上涨5.44%,报13.19美元/股。\n\n公司最新财报显示,Regenxbio Inc.实现营业收入2230万美元,虽然净利润为-5299万美元,但每股收益、毛利等主要指标表现不俗。这或许是推动股价上涨的一个原因。\n\n另一个值得关注的因素是,目前有10家机构对该股进行了评级,其中100%的机构给予了\"买入\"评级,看好公司的长期发展前景。这无疑提振了投资者的信心,推动了股价的上涨。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RGNX"],"gpt_icon":0},{"id":"2457072574","title":"Regenxbio Inc.盘中异动 下午盘股价大涨5.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457072574","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457072574?lang=zh_cn&edition=full","pubTime":"2024-08-07 02:19","pubTimestamp":1722968377,"startTime":"0","endTime":"0","summary":"北京时间2024年08月07日02时19分，Regenxbio Inc.股票出现波动，股价急速拉升5.44%。截至发稿，该股报13.19美元/股，成交量26.8329万股，换手率0.54%，振幅7.83%。Regenxbio Inc.股票所在的生物技术行业中，整体涨幅为2.14%。Regenxbio Inc.公司简介：Regenxbio Inc是一家生物技术公司。Regenxbio平台针对的疾病是代谢性疾病、神经退行性疾病和视网膜疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240807021937aefd899a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240807021937aefd899a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4563","BK4139","RGNX","BK4505"],"gpt_icon":0},{"id":"2457336910","title":"巴克莱：维持Regenxbio(RGNX.US)评级，由增持调整至增持评级, 目标价由55.00美元调整至50.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2457336910","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457336910?lang=zh_cn&edition=full","pubTime":"2024-08-06 07:52","pubTimestamp":1722901923,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","RGNX","BK4563","BK4505"],"gpt_icon":0},{"id":"2456028948","title":"Regenxbio Inc.盘中异动 股价大跌7.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2456028948","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456028948?lang=zh_cn&edition=full","pubTime":"2024-08-02 21:33","pubTimestamp":1722605619,"startTime":"0","endTime":"0","summary":"北京时间2024年08月02日21时33分，Regenxbio Inc.股票出现波动，股价大幅跳水7.14%。截至发稿，该股报12.36美元/股，成交量4.1262万股，换手率0.08%，振幅7.29%。Regenxbio Inc.股票所在的生物技术行业中，整体跌幅为0.52%。Regenxbio Inc.公司简介：Regenxbio Inc是一家生物技术公司。Regenxbio平台针对的疾病是代谢性疾病、神经退行性疾病和视网膜疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408022133399f090679&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408022133399f090679&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4563","RGNX","BK4139","BK4505"],"gpt_icon":0},{"id":"2456328866","title":"Regenxbio Inc: 美国银行全球研究将目标价从33美元下调至28美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2456328866","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456328866?lang=zh_cn&edition=full","pubTime":"2024-08-02 20:33","pubTimestamp":1722602029,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE00BBT3K403.USD","LU0128525689.USD","LU0130103400.USD","LU1267930227.SGD","BK4559","LU0477156797.USD","IE00BZ1G4Q59.USD","LU1074936037.SGD","LU2129689514.USD","LU1201861165.SGD","LU2129689605.HKD","LU0417517546.SGD","LU0149725797.USD","LU1162221912.USD","LU1894683264.USD","LU1363072403.SGD","LU0208291251.USD","LU1894683348.USD","LU2129689431.USD","RGNX","LU0256863811.USD","LU1496350502.SGD","LU0320765646.SGD","LU0052756011.USD","IE00B19Z3B42.SGD","BK4505","LU0648000940.SGD","IE00BFXG1179.USD","BAC","LU1496350171.SGD","LU0640476718.USD","LU1718418525.SGD","LU1791807156.HKD","LU0234572021.USD","LU1280957306.USD","LU0070302665.USD","BK4581","LU0980610538.SGD","LU0310800965.SGD","IE00B7SZLL34.SGD","LU1668664300.SGD","LU1201861249.SGD","IE00BLSP4452.SGD","BK4504","IE00B19Z3581.USD","LU0648001328.SGD","LU2133065610.SGD","BK4553","LU0256863902.USD","BK4588"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.regenxbio.com","stockEarnings":[{"period":"1week","weight":-0.0045},{"period":"1month","weight":0.0816},{"period":"3month","weight":-0.0906},{"period":"6month","weight":-0.3033},{"period":"1year","weight":-0.418},{"period":"ytd","weight":-0.3794}],"compareEarnings":[{"period":"1week","weight":-0.0038},{"period":"1month","weight":0.0234},{"period":"3month","weight":0.0704},{"period":"6month","weight":0.1207},{"period":"1year","weight":0.3195},{"period":"ytd","weight":0.2483}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Regenxbio Inc.于2008年7月16日成立。该公司是一家领先的生物技术公司，专注于重组腺相关病毒（AAV）基因疗法的发展，商业化和许可。在AAV基因治疗，病毒基因从所述AAV，一个小的非致病性感冒病毒除去，产生所谓的载体的生物递送载体。治疗性基因的序列然后被插入，形成重组载体。该公司专有的AAV基因交付平台（资产净值技术平台）包括专有权超过100新型AAV载体，包括AAV7，AAV8，AAV9和AAVrh10（NAV向量）。公司的使命是将患者的生命从严重的疾病，患有显著未满足的医疗需求，通过开发和商业化直接给予体内基因治疗产品，或者体内，根据其资产净值技术平台上。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.091191},{"month":2,"riseRate":0.333333,"avgChangeRate":0.042372},{"month":3,"riseRate":0.555556,"avgChangeRate":0.007107},{"month":4,"riseRate":0.555556,"avgChangeRate":0.001544},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.016188},{"month":6,"riseRate":0.666667,"avgChangeRate":0.061006},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.005994},{"month":8,"riseRate":0.333333,"avgChangeRate":0.014099},{"month":9,"riseRate":0.555556,"avgChangeRate":0.070275},{"month":10,"riseRate":0.3,"avgChangeRate":-0.099147},{"month":11,"riseRate":0.7,"avgChangeRate":0.190813},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.046575}],"exchange":"NASDAQ","name":"Regenxbio Inc","nameEN":"Regenxbio"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Regenxbio Inc(RGNX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Regenxbio Inc(RGNX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Regenxbio Inc,RGNX,Regenxbio Inc股票,Regenxbio Inc股票老虎,Regenxbio Inc股票老虎国际,Regenxbio Inc行情,Regenxbio Inc股票行情,Regenxbio Inc股价,Regenxbio Inc股市,Regenxbio Inc股票价格,Regenxbio Inc股票交易,Regenxbio Inc股票购买,Regenxbio Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Regenxbio Inc(RGNX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Regenxbio Inc(RGNX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}